Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2019 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2019 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro

  • Authors:
    • Masayoshi Yamaguchi
    • Robert M. Levy
  • View Affiliations / Copyright

    Affiliations: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095‑1732, USA, Department of Clinical Development, Primus Pharmaceuticals, Inc., Scottsdale, AZ 85251, USA
  • Pages: 4312-4318
    |
    Published online on: March 29, 2019
       https://doi.org/10.3892/etm.2019.7452
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

It has been demonstrated that the combination of three botanical factors of (+)‑catechin, baicalin and β‑caryophyllene, which exhibit anti‑inflammatory effects, with comparatively lower concentrations of each factor, demonstrating a potent synergistic‑suppressive effect on the growth of mouse macrophage RAW264.7 cells in vitro, and suggesting it may function as a pharmacologic tool for managing inflammatory diseases. The present study was undertaken to determine the suppressive effects of (+)‑catechin, baicalin or β‑caryophyllene on the production of inflammatory cytokines, including TNF‑α, IL‑6 and IL‑1β, which was enhanced by lipopolysaccharide (LPS) in RAW264.7 cells in vitro. The cells were cultured for 3 days without botanical factors, followed by incubation for 5 h in the presence of either vehicle, (+)‑catechin [1 µg/ml (3.45 µM)], baicalin [1 µg/ml (2.24 µM)], or β‑caryophyllene [1 µg/ml (5 µM)] with or without LPS (100 ng/ml); this did not have significant effects on the number of RAW264.7 cells. The production of TNF‑α, IL‑6 and IL‑1β was not altered by the addition of (+)‑catechin, baicalin, β‑caryophyllene, or the three combined factors in RAW264.7 cells without LPS. LPS treatment caused a marked production of TNF‑α, IL‑6, and IL‑1β. This enhancement was suppressed by the addition of (+)‑catechin, baicalin or β‑caryophyllene. Of note, the production of these cytokines was additively suppressed by the combination of the three factors in macrophages. Thus, the combination of (+)‑catechin, baicalin and β‑caryophyllene was found to reveal a potent suppressive effect on cytokine production in macrophages in vitro. This composition may be a useful tool as a potent anti‑inflammatory agent.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Villanueva-Romero R, Gutiérrez-Cañas I, Carrión M, Pérez García S, Seoane IV, Martínez C, Gomariz RP and Juarranz Y: The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of Th subsets in rheumatoid arthritis. J Immunol Res. 2018:60437102018. View Article : Google Scholar : PubMed/NCBI

2 

Kalaiselvi P, Rajashree K, Bharathi Priya L and Padma VV: Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol-induced toxicity through anti-oxidative and anti-inflammatory mechanisms in HT-29 cells. Food Chem Toxicol. 56:110–118. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Morrison M, van der Heijden R, Heeringa P, Kaijzel E, Verschuren L, Blomhoff R, Kooistra T and Kleemann R: Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis. 233:149–156. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Qian Y, Chen Y, Wang L and Tou J: Effects of baicalin on inflammatory reaction, oxidative stress and PKDl and NF-kB protein expressions in rats with severe acute pancreatitis1. Acta Cir Bras. 33:556–564. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Bitto A, Squadrito F, Irrera N, Pizzino G, Pallio G, Mecchio A, Galfo F and Altavilla D: Flavocoxid, a nutraceutical approach to blunt inflammatory conditions. Mediators Inflamm. 2014:7908512014. View Article : Google Scholar : PubMed/NCBI

6 

Sharma C, Al Kaabi JM, Nurulain SM, Goyal SN, Kamal MA and Ojha S: Polypharmacological properties and therapeutic potential of β-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise. Curr Pharm Des. 22:3237–3264. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Klauke AL, Racz I, Pradier B, Markert A, Zimmer AM, Gertsch J and Zimmer A: The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol. 24:608–620. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M and Zimmer A and Zimmer A: Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA. 105:9099–9104. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Ormeño E, Baldy V, Ballini C and Fernandez C: Production and diversity of volatile terpenes from plants on calcareous and siliceous soils: effect of soil nutrients. J Chem Ecol. 34:1219–1229. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, Bagetta G, Sakurada T and Sakurada S: Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception. Eur J Pain. 17:664–675. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Paula-Freire LI, Andersen ML, Gama VS, Molska GR and Carlini EL: The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine. 21:356–362. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Chavan MJ, Wakte PS and Shinde DB: Analgesic and anti-inflammatory activity of Caryophyllene oxide from Annona squamosa L. bark. Phytomedicine. 17:149–151. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Ghelardini C, Galeotti N, Di Cesare Mannelli L, Mazzanti G and Bartolini A: Local anaesthetic activity of beta-caryophyllene. Farmaco. 56:387–389. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Martinez RM, Zarpelon AC, Cardoso RD, Vicentini FT, Georgetti SR, Baracat MM, Andrei CC, Moreira IC, Verri WA Jr and Casagrande R: Tephrosia sinapou ethyl acetate extract inhibits inflammatory pain in mice: Opioid receptor dependent inhibition of TNFα and IL-1β production. Pharm Biol. 51:1262–1271. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Yamaguchi M and Levy RM: The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro. Int J Mol Med. 38:1940–1946. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Pomari E, Stefanon B and Colitti M: Effect of plant extracts on H2O2-induced inflammatory gene expression in macrophages. J Inflamm Res. 7:103–112. 2014.PubMed/NCBI

17 

Yamaguchi M, Vikulina T, Arbiser JL and Weitzmann MN: Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis. Curr Mol Med. 14:783–792. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Yamaguchi M and Weitzmann MN: The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation. Int J Mol Med. 30:708–712. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Yamaguchi M and Daimon Y: Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: involvement of intracellular signaling factors and cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Izumi T and Yamaguchi M: Overexpression of regucalcin suppresses cell death in cloned rat hepatoma H4-II-E cells induced by tumor necrosis factor-alpha or thapsigargin. J Cell Biochem. 92:296–306. 2004. View Article : Google Scholar : PubMed/NCBI

21 

Okuno T, Gijón MA, Zarini S, Martin SA, Barkley RM, Johnson CA, Ohba M, Yokomizo T and Murphy RC: Altered eicosanoid production and phospholipid remodeling during cell culture. J Lipid Res. 59:542–549. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG and Moulinoux JP: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem. 243:527–536. 1997. View Article : Google Scholar : PubMed/NCBI

23 

Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L and Baskaran R: Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Serrano-Nascimento C, da Silva Teixeira S, Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute inhibitory effect of iodide excess on sodium/iodide symporter expression and activity involves the PI3K/Akt signaling pathway. Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Chen S, Wang Y, Ruan W, Wang X and Pan C: Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity. Oncol Lett. 8:2333–2339. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Zhao Y, Jing Z, Li Y and Mao W: Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol Rep. 36:567–572. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Echizen K, Hirose O, Maeda Y and Oshima M: Inflammation in gastric cancer: interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. Cancer Sci. 107:391–397. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Lin CC, Chan CM, Huang YP, Hsu SH, Huang CL and Tsai SJ: Methylglyoxal activates NF-κB nuclear translocation and induces COX-2 expression via a p38-dependent pathway in synovial cells. Life Sci. 149:25–33. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Li N, Liu BW, Ren WZ, Liu JX, Li SN, Fu SP, Zeng YL, Xu SY, Yan X, Gao YJ, et al: GLP-2 attenuates LPS-induced inflammation in BV-2 cells by inhibiting ERK1/2, JNK1/2 and NF-κB signaling pathway. Int J Mol Sci. 17:1902016. View Article : Google Scholar : PubMed/NCBI

30 

Cha SM, Cha JD, Jang EJ, Kim GU and Lee KY: Sophoraflavanone G prevents Streptococcus mutans surface antigen I/II-induced production of NO and PGE2 by inhibiting MAPK-mediated pathways in RAW 264.7 macrophages. Arch Oral Biol. 68:97–104. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Xu X, Yin P, Wan C, Chong X, Liu M, Cheng P, Chen J, Liu F and Xu J: Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation. Inflammation. 37:956–965. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Cho BO, So Y, Jin CH, Nam BM, Yee ST and Jeong IY: 3-deoxysilybin exerts anti-inflammatory effects by suppressing NF-κB activation in lipopolysaccharide-stimulated RAW264.7 macrophages. Biosci Biotechnol Biochem. 78:2051–2058. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Zhao G, Zhang T, Ma X, Jiang K, Wu H, Qiu C, Guo M and Deng G: Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury. Oncotarget. 8:68153–68164. 2017.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yamaguchi M and Levy RM: The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro. Exp Ther Med 17: 4312-4318, 2019.
APA
Yamaguchi, M., & Levy, R.M. (2019). The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro. Experimental and Therapeutic Medicine, 17, 4312-4318. https://doi.org/10.3892/etm.2019.7452
MLA
Yamaguchi, M., Levy, R. M."The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro". Experimental and Therapeutic Medicine 17.5 (2019): 4312-4318.
Chicago
Yamaguchi, M., Levy, R. M."The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro". Experimental and Therapeutic Medicine 17, no. 5 (2019): 4312-4318. https://doi.org/10.3892/etm.2019.7452
Copy and paste a formatted citation
x
Spandidos Publications style
Yamaguchi M and Levy RM: The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro. Exp Ther Med 17: 4312-4318, 2019.
APA
Yamaguchi, M., & Levy, R.M. (2019). The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro. Experimental and Therapeutic Medicine, 17, 4312-4318. https://doi.org/10.3892/etm.2019.7452
MLA
Yamaguchi, M., Levy, R. M."The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro". Experimental and Therapeutic Medicine 17.5 (2019): 4312-4318.
Chicago
Yamaguchi, M., Levy, R. M."The combination of catechin, baicalin and β‑caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro". Experimental and Therapeutic Medicine 17, no. 5 (2019): 4312-4318. https://doi.org/10.3892/etm.2019.7452
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team